Study details
Enrolling now
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
NCT IDNCT05454488ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 3.5 years
Ages
18+
Sex
Male only
Locations
1 site in TX
About this study
Researchers are testing if using cryotherapy to treat only the part of the prostate known to contain cancer is effective in controlling prostate cancer. The trial will measure how well the treatment works by looking at whether the cancer returns in the treated area and how it affects quality of life.
Based on ClinicalTrials.gov records.
What participants do
- 1.Quality-of-life Questionnaires
- 2.Standard of Care
- 3.Take Focal Cryoablation
PhasePhase 2
Primary goalQuality-of-life Questionnaires
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Quality-of-life Questionnaires
Body systems
Oncology